↓ Skip to main content

Targeting BCMA to Treat Multiple Myeloma: Updates From the 2021 ASH Annual Meeting

Overview of attention for article published in Frontiers in immunology, March 2022
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
4 news outlets
twitter
15 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
34 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Targeting BCMA to Treat Multiple Myeloma: Updates From the 2021 ASH Annual Meeting
Published in
Frontiers in immunology, March 2022
DOI 10.3389/fimmu.2022.839097
Pubmed ID
Authors

Ruiting Guo, Wenyi Lu, Yi Zhang, Xinping Cao, Xin Jin, Mingfeng Zhao

X Demographics

X Demographics

The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 34 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 21%
Student > Bachelor 6 18%
Student > Ph. D. Student 3 9%
Student > Doctoral Student 1 3%
Professor > Associate Professor 1 3%
Other 0 0%
Unknown 16 47%
Readers by discipline Count As %
Medicine and Dentistry 5 15%
Biochemistry, Genetics and Molecular Biology 4 12%
Immunology and Microbiology 3 9%
Agricultural and Biological Sciences 2 6%
Nursing and Health Professions 2 6%
Other 2 6%
Unknown 16 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 33. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 December 2023.
All research outputs
#1,265,727
of 26,174,669 outputs
Outputs from Frontiers in immunology
#1,132
of 33,022 outputs
Outputs of similar age
#30,651
of 453,311 outputs
Outputs of similar age from Frontiers in immunology
#55
of 1,636 outputs
Altmetric has tracked 26,174,669 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 33,022 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 453,311 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 1,636 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.